InvestorsHub Logo
Post# of 251810
Next 10
Followers 829
Posts 119628
Boards Moderated 14
Alias Born 09/05/2002

Re: north40000 post# 186873

Sunday, 02/01/2015 12:05:22 PM

Sunday, February 01, 2015 12:05:22 PM

Post# of 251810

Where did Harvoni therapy enter the picture? I thought original ESRX deal gave exclusivity to V-P in preferred formulary as opposed to Sovaldi…

No, the payers' decision for the GT1 patient pool is V-Pak vs Harvoni. Sovaldi is essentially an obsolete product for GT1 patients.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.